Current role
Biotechnology · Healthcare
Board Member
2025-06-25–present
Heather Preston, M.D.
Board Member
Aligos Therapeutics, Inc. (ALGS)Equibles does not estimate personal net worth.
Get an email with a short summary when Aligos Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ALGS alertsAbout Heather Preston, M.D.
Heather Preston, M.D. is recorded as Board Member at Aligos Therapeutics, Inc. (ALGS) since June 25, 2025. Aligos Therapeutics, Inc. reported in an 8-K filed June 26, 2025 that Heather Preston, M.D. was appointed Class II director. Aligos Therapeutics, Inc. reported in an 8-K filed August 8, 2024 that Heather Preston, M.D. was appointed Class II director, effective August 7, 2024. Aligos Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Aligos Therapeutics, Inc. includes Lawrence M. Blatt (CEO and Board Member), Lesley Ann Calhoun (CFO and COO), Lucinda Y. Quan (General Counsel) and 7 others.
“Proposal 1. The election of three Class II directors to hold office until the 2028 annual meeting of stockholders or until their respective successor is elected.”
“approved an increase in the number of authorized directors on the Board to seven and appointed Heather Preston, M.D. and Margarita Chavez, J.D., to the Board to fill the newly created directorships resulting from the increase in the number of authorized directors.”
Affiliation history
-
Current
2025-06-25–present
Company network
Leadership on record at Aligos Therapeutics, Inc.
- Lawrence M. Blatt CEO, Board Member
- Lesley Ann Calhoun CFO, COO
- Lucinda Y. Quan General Counsel
- Nikhil Aneja Chief Accounting Officer
- Bridget Martell Board Member
- Bridget Martell, M.A., M.D. Board Member
- Bridget Martell, M.D. Board Member
- Carole Nuechterlein Board Member
- Carole Nuechterlein, J.D. Board Member
- Heather Preston Board Member